Inactive Instrument

Other languages Hercules Technology Growth Capital Inc Nasdaq

Equities

US4270965084

Real-time Estimate Cboe BZX Other stock markets 19:41:29 28/05/2024 BST			5-day change	1st Jan Change
19.34 ^USD	0.00%		0.00%	0.00%

05-17	UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating	MT
05-15	Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise	05-09
Verona Pharma Signs Financing Agreements for Up to $650 Million	05-09
Hercules Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02
Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024	04-30
Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment	04-30
Bluebird bio to Restate Financial Statements; Shares Fall	03-26
Sector Update: Health Care Stocks Edge Up Late Monday Afternoon	03-18
Sector Update: Health Care	03-18
Bluebird bio Secures $175 Million Term Loan Facility	03-18
Hercules Capital Posts Increased Q4 Net, Total Investment Income	02-15
Hercules Capital, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-15
Hercules Capital, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-15
Hercules Capital, Inc. Declares Cash Distribution for the Fourth Quarter 2023, Dividend Payable on March 6, 2024	02-13
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 Per Share, Payment on March 6, 2024	02-13
Hercules Capital's Q3 Net Investment Income Rises	11-02
Hercules Capital, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-02
Hercules Capital, Inc. Declares Total Cash Distribution the Third Quarter 2023, Payable on November 22, 2023	31/10/23
Hercules Capital Appoints Nikos Theodosopoulos an Independent Member of its Board of Directors and to Serve on Audit Committee	25/09/23
Sector Update: Financial Stocks Advancing Late Wednesday Afternoon	30/08/23
Sector Update: Financial	30/08/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Hercules Technology Growth Capital Inc Nasdaq

Equities

US4270965084

Other languages

Filters